 14. Active and clinically uncontrolled autoimmune disease as determined by the investigator. Subjects with controlled autoimmune diseases must be considered to be clinically stable in the opinion of the investigator e.g. subjects with systemic lupus erythematosus SLE and no recent flares are not excluded. The investigator will consult with the referring physician if it is necessary to confirm the stability of an autoimmune disease. 